*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : EL8600000
CHEMICAL NAME : 1-Butanone,
1-(4-fluorophenyl)-4-(1,4,5,6-tetrahydro-8-hydroxy-6,
11-dimethyl-2,6-metha no- 3-benzazocin-3(2H)-yl)-,
(2-alpha,6-alpha,11R*)-
CAS REGISTRY NUMBER : 56390-16-0
LAST UPDATED : 199206
DATA ITEMS CITED : 11
MOLECULAR FORMULA : C24-H28-F-N-O2
MOLECULAR WEIGHT : 381.53
WISWESSER LINE NOTATION : T C666 A KN&TTJ A1 B1 EQ K3VR DF
COMPOUND DESCRIPTOR : Drug
SYNONYMS/TRADE NAMES :
* 2-(3-(p-Fluorobenzoyl)-1-propyl)-5-alpha,9-alpha-dimethyl-2'-hydroxy-6,7
-benzomorphan
* ID-1229
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >1 gm/kg
TOXIC EFFECTS :
Behavioral - ataxia
Vascular - regional or general arteriolar or venous dilation
Lungs, Thorax, or Respiration - other changes
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 25,795,1975
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 82 mg/kg
TOXIC EFFECTS :
Behavioral - muscle weakness
Behavioral - ataxia
Vascular - regional or general arteriolar or venous dilation
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 25,795,1975
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 520 mg/kg
TOXIC EFFECTS :
Behavioral - muscle weakness
Behavioral - ataxia
Vascular - regional or general arteriolar or venous dilation
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 25,795,1975
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 24 mg/kg
TOXIC EFFECTS :
Behavioral - muscle weakness
Behavioral - ataxia
Vascular - regional or general arteriolar or venous dilation
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 25,795,1975
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >500 mg/kg
TOXIC EFFECTS :
Behavioral - ataxia
Vascular - regional or general arteriolar or venous dilation
Lungs, Thorax, or Respiration - other changes
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 25,795,1975
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 112 mg/kg
TOXIC EFFECTS :
Behavioral - muscle weakness
Behavioral - ataxia
Vascular - regional or general arteriolar or venous dilation
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 25,795,1975
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 270 mg/kg
TOXIC EFFECTS :
Behavioral - muscle weakness
Behavioral - ataxia
Vascular - regional or general arteriolar or venous dilation
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 25,795,1975
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 32 mg/kg
TOXIC EFFECTS :
Behavioral - muscle weakness
Behavioral - ataxia
Lungs, Thorax, or Respiration - other changes
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 25,795,1975
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 75 mg/kg
TOXIC EFFECTS :
Behavioral - muscle weakness
Behavioral - ataxia
Vascular - regional or general arteriolar or venous dilation
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 25,795,1975
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 7850 ug/kg
TOXIC EFFECTS :
Behavioral - muscle weakness
Behavioral - ataxia
Vascular - regional or general arteriolar or venous dilation
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 25,795,1975
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : >100 mg/kg
TOXIC EFFECTS :
Behavioral - ataxia
Vascular - regional or general arteriolar or venous dilation
Lungs, Thorax, or Respiration - other changes
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 25,795,1975
*** END OF RECORD ***
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
1-Butanone,1-(4-fluorophenyl)-4-(2-hydroxyspiro(benzofuran-3(2H),4'-piperidin)-1'-yl)-
| 73962-20-6 |
1-Butanone,1-(4-fluorophenyl)-4-((4-methoxy-4-(2-methoxyphenyl)cyclohexyl)amino)-, hydrochloride, trans-
| 73962-20-6 |
1-Butanone,1-(4-fluorophenyl)-4-((4-methoxy-4-(2-methylphenyl)cyclohexyl)amino)-, hydrochloride, cis-
| 42020-72-4 |
1-Butanone,1-(4-fluorophenyl)-4-(4-(2-(4-methoxyphenoxy)ethyl)-1-piperazinyl)-, dihydrochloride
| 40986-94-5 |
1-Butanesulfinic acid, 4-(decyldithio)-, sodium salt,hydrate
| 40986-94-5 |
1-Butanone,1-(4-fluorophenyl)-4-(1-(3-methoxyphenyl)-6-azabicyclo(3.2.1)oct-6-yl)-, hydrochloride, (+-)-
| 61098-73-5 |
1-Butanone,1-(4-fluorophenyl)-4-(4-((4-methoxyphenyl)methyl)-1-piperazinyl)-, hydrochloride
| 27218-32-2 |
1-Butanone,1-(4-fluorophenyl)-3-methyl-4-(4-morpholinyl)-,(+-)-, (Z)-2-butenedioate (1:1)
| 36477-21-1 |
1-Butanone,1-(4-fluorophenyl)-4-naphthalen-1,4-imin-9-yl-,hydrochloride
| 35806-09-8 |
1-Butanone,1-(4-fluorophenyl)-4-(4-(2-(2-nitrophenoxy)ethyl)-1-piperazinyl)-, dihydrochloride
| 40987-00-6 |
1-Butanone,1-(4-fluorophenyl)-4-(4-(2-(3-nitrophenoxy)ethyl)-1-piperazinyl)-, dihydrochloride
| 40987-01-7 |
1-Butanone,1-(4-fluorophenyl)-4-(4-(2-(4-nitrophenoxy)ethyl)-1-piperazinyl)-, dihydrochloride
| 40986-90-1 |
1-Butanone,1-(4-fluorophenyl)-4-(1,3,4,4a,5,6,11,11a-octahydro-2H-pyrido(4,3-b)carbaz ol- 2-yl-, cis-,(E)-2-butenedioate (1:1)
| 112853-80-2 |
1-Butanone,1-(4-fluorophenyl)-4-(1,3,4,4a,5,6,11,11a-octahydro-2H-pyrido(4,3-b)carbaz ol- 2-yl)-, trans-,(E)-2-butenedioate (1:1)
| 112853-81-3 |
1-Butanone,1-(4-fluorophenyl)-4-(1-phenyl-6-azabicyclo(3.2.1)oct-6-yl)-, hydrobromide, (+-)-
| 61098-64-4 |
1-Butanesulfinic acid,4-(((dimethylamino)thioxomethyl)dithio)-, sodium salt
| 33286-57-6 |
1-Butanone,1-(4-fluorophenyl)-2-((4-phenyl-1-piperazinyl)methylene)-
| 65201-29-8 |
1-Butanone,1-(4-fluorophenyl)-4-(4-(2-pyridinyl)-1-piperazinyl)-, (Z)-2-butenedioate (1:2)
| 59698-53-2 |
1-Butanone,1-(4-fluorophenyl)-4-(1,4,5,6-tetrahydro-8-hydroxy-6,11-dimethyl-2,6-metha no- 3-benzazocin-3(2H)-yl)-,(2-alpha,6-alpha,11R*)-
| 56390-16-0 |
1-Butanone,1-(4-fluorophenyl)-4-(5,6,11,11a-tetrahydro-1H-imidazo(1',5':1,6) pyrido(3,4-b)indol-2(3H)-yl)-
| 77871-94-4 |
1-Butanone,1-(4-fluorophenyl)-4-(4-(5,6,7,8-tetrahydro-2-naphthalenyl)-1-piperazinyl) -, (Z)-2-butenedioate (1:1)
| 57537-18-5 |
2-Butanone, 4-(2-furyl)-
| 699-17-2 |
2-Butanone, 4-(hexahydro-1H-azepin-1-yl)-,hydrochloride
| 111472-70-9 |
1-Butanone,4-(hexahydro-1H-azepin-1-yl)-1-(2-thiazolyl)-,hydrobromide
| 33537-62-1 |
1-Butanone,4-(hexahydro-1H-azepin-1-yl)-1-(3-thienyl)-,hydrobromide
| 31634-34-1 |
1-Butanone,4-(hexahydro-1H-azepin-1-yl)-1-(3-thienyl)-,hydrochloride
| 31634-35-2 |
1-Butanesulfinic acid, 4,4'-dithiobis-, disodium salt
| 34915-82-7 |
1-Butanone,4-(hexahydro-1H-azepin-1-yl)-1-(3-thienyl)-, oxime,hydrochloride
| 31634-22-7 |
2-Butanone,4-(3,4,6,7,12,12a-hexahydropyrazino(1',2':1,6)pyrido(3,4-b)indol-2(1H)-yl) -, (+-)-
| 42021-45-4 |
1-Butanone,4-(3,4,6,7,12,12a-hexahydropyrazino(1',2':1,6)pyrido(3,4-b)indol-2(1H)-yl) -1- (4-methylphenyl)-, (+-)-
| 42021-42-1 |
2-Butanone, 3-(1-hexenyl-ONN-azoxy)-, (S-(Z,E))-
| 122566-70-5 |
1-Butanone, 1-(4-(hexylamino)-3-hydroxyphenyl)-
| 135420-22-3 |
2-Butanone, 3-hydroxy-
| 513-86-0 |
2-Butanone, 1-hydroxy-, acetate
| 1575-57-1 |
1-Butanone,4-((2-hydroxyethyl)amino)-1-(2-methylphenyl)-
| 133845-32-6 |
1-Butanone,4-((2-hydroxyethyl)amino)-1-(3-methyl-2-thienyl)-
| 141809-40-7 |
1-Butanone, 4-((2-hydroxyethyl)amino)-1-phenyl-
| 133845-30-4 |
2,3-Butanedione, 1-(dibenzylamino)-, 2-oxime
| 63732-21-8 |
1-Butanesulfinic acid, 4-((p-methoxybenzyl)dithio)-,sodium salt, hemihydrate
| 63732-21-8 |
1-Butanone, 4-((2-hydroxyethyl)amino)-1-(2-thienyl)-
| 141809-39-4 |
1-Butanone,4-((2-hydroxyethyl)amino)-1-(2,4,6-trimethylphenyl)-
| 141809-43-0 |
1-Butanone, 4-((2-hydroxyethyl)methylamino)-1-phenyl-
| 141809-35-0 |
1-Butanone,4-((2-hydroxyethyl)methylamino)-1-(2-thienyl)-
| 141809-41-8 |
2-Butanone, 4-(4-hydroxy-3-methoxyphenyl)-
| 122-48-5 |
1-Butanone, 1-(3-hydroxy-4-(methylamino)phenyl)-
| 123172-48-5 |
2-Butanone, 4-(p-hydroxyphenyl)-
| 5471-51-2 |
2-Butanone, 4-(p-hydroxyphenyl)-, acetate
| 3572-06-3 |
1-Butanone,4-(1-(3-hydroxyphenyl)-6-azabicyclo(3.2.1)oct-6-yl)-1-phenyl-, hydrochloride, (+-)-
| 61098-71-3 |
2-Butanone,4-(4-hydroxy-1-piperidinyl)-3-((4-hydroxy-1-piperidinyl)methyl)-
| 70525-21-2 |
1-Butanesulfinic acid, 4,4'-pentathiobis-, disodiumsalt, hydrate (4:8:1)
| 70525-21-2 |
|
|